[19] |
Babjuk M, Burger M, Compérat E, et al. EAU Guidelines on Non-muscle-invasive Bladder Cancer (T1, T1 and CIS), in EAU Guidelines, Edn. presented at the 34th EAU Annual Congress Barcelona[EB/OL]. 2019, EAU Guidelines Office.
URL
|
[20] |
Munoz JJ, Ellison LM. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades[J]. J Urol, 2000, 164(5): 1523-1525.
|
[21] |
Shariat SF, Favaretto RL, Gupta A, et al. Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma[J]. World J Urol, 2011, 29(4): 481-486.
|
[22] |
Browne R F J, Meehan C P, Colville J, et al. Transitional cell carcinoma of the upper urinary tract: spectrum of imaging findings[J]. Radiographics, 2005, 25(6): 1609-1627.
|
[23] |
Tawfiek E R, Bagley D H. Upper-tract transitional cell carcinoma[J]. Urology, 1997, 50(3): 321-329.
|
[24] |
Gunia S, Erbersdobler A, Koch S, et al. Protein gene product 9.5 is diagnostically helpful in delineating high-grade renal cell cancer involving the renal medullary/sinus region from invasive urothelial cell carcinoma of the renal pelvis[J]. Hum Pathol, 2013, 44(5): 712-717.
|
[25] |
Abouassaly R, Alibhai S MH, Shah N, et al. Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma[J]. Urology, 2010, 76(4): 895-901.
|
[26] |
Jeldres C, Sun M, Isbarn H, et al. A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma[J]. Urology, 2010, 75(2): 315-320.
|
[27] |
Crivelli J J, Xylinas E, Kluth L A, et al. Effect of smoking on outcomes of urothelial carcinoma: a systematic review of the literature[J]. Eur Urol, 2014, 65(4): 742-754.
|
[1] |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017[J]. CA Cancer J Clin, 2017, 67(1): 7-30.
|
[2] |
Choueiri T K, Motzer R J. Systemic therapy for metastatic renal-cell carcinoma[J]. N Engl J Med, 2017, 376(4): 354-366.
|
[3] |
Moch H, Cubilla AL, Humphrey PA, et al. The 2016 WHO classification of tumours of the urinary system and male genital organs-part A: renal, penile, and testicular tumours[J]. Eur Urol, 2016, 70(1): 93-105.
|
[4] |
Capitanio U, Cloutier V, Zini L, et al. A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study[J]. BJU int, 2009, 103(11): 1496-1500.
|
[5] |
Guinan P, Vogelzang NJ, Randazzo R, et al. Renal pelvic cancer: a review of 611 patients treated in Illinois 1975-1985[J]. Urology, 1992, 40(5): 393-399.
|
[6] |
Lopez-Beltran A, Scarpelli M, Montironi R, et al. 2004 WHO classification of the renal tumors of the adults[J]. Eur Urol, 2006, 49(5): 798-805.
|
[7] |
Zhao M, He X, Teng X. Mucinous tubular and spindle cell renal cell carcinoma: a review of clinicopathologic aspects[J]. Diagn Pathol, 2015, 10(1): 168.
|
[8] |
Yang G, Breyer B N, Weiss D A, et al. Mucinous tubular and spindle cell carcinoma of the kidney[J]. J Urol, 2010, 183(2): 738.
|
[9] |
Zhu Q, Zhu W, Wang Z, et al. Clinical and CT imaging features of mucinous tubular and spindle cell carcinoma[J]. Chin Med J(Engl), 2014, 127(7): 1278-1283.
|
[10] |
Srigley JR, Delahunt B, Eble JN, et al. The International Society of Urological Pathology (ISUP) vancouver classification of renal neoplasia[J]. Am J Surg Pathol, 2013, 37(10): 1469-1489.
|
[11] |
Reuter V E, Argani P, Zhou M, et al. Best practices recommendations in the application of immunohistochemistry in the kidney tumors: report from the International Society of Urologic Pathology consensus conference[J]. Am J Surg Pathol, 2014, 38(8): e35-e49.
|
[12] |
Kenney P A, Vikram R, Prasad S R, et al. Mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney: a detailed study of radiological, pathological and clinical outcomes[J]. BJU int, 2015, 116(1): 85-92.
|
[13] |
Cornelis F, Ambrosetti D, Rocher L, et al. CT and MR imaging features of mucinous tubular and spindle cell carcinoma of the kidneys. A multi-institutional review[J]. Eur Radiol, 2017, 27(3): 1087-1095.
|
[14] |
Dimitriou R J, Gattuso P, Coogan CL. Carcinosarcoma of the renal pelvis[J]. Urology, 2000, 56(3): 508.
|
[15] |
Lopez-Beltran A, Montironi R, Carazo JL, et al. Primary renal osteosarcoma[J]. Am J Clin Pathol, 2014, 141(5): 747-752.
|
[16] |
邝菲, 钟群, 聂枚. 肾脏癌肉瘤的影像表现[J]. 临床放射学杂志, 2010, 29(10): 1356-1359.
|
[17] |
田溪泉, 邢念增. 肾脏癌肉瘤和肉瘤样癌的病理及临床特点[J]. 临床泌尿外科杂志, 2008, 23(8): 584-586.
|
[18] |
Abu-Khalaf M M, Raza M A, Hatzis C, et al. Efficacy and tolerability of combination cisplatin and ifosfamide chemotherapy with vaginal cuff brachytherapy in the first line treatment of uterine carcinosarcoma[J]. Eur J Gynaecol oncol, 2016, 37(2): 199-203.
|